CSL Behring is a provider of life-saving medicines. It develops and delivers a range of medicines to treat disorders such as haemophilia and primary immune deficiencies, and vaccines to prevent influenza. CSL Behring's therapies are also used in cardiac surgery, organ transplantation, and burn treatment.
|Company Name||Date||Deal Size|
|Vitaeris Inc||June 08, 2020|
CSL Behring revenue breakdown by business segment: 51.1% from Immunoglobulins, 14.3% from Hemophilia, 8.1% from Albumin, 21.6% from Specialty and 4.8% from Other
CSL Behring has 9.26k Twitter Followers. The number of followers has increased 0.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was CSL Behring founded?
CSL Behring was founded in 1904.
Who are CSL Behring key executives?
CSL Behring's key executives are Paul Perreault, Bill Campbell and John Levy.
How many employees does CSL Behring have?
CSL Behring has 7,056 employees.
What is CSL Behring revenue?
Latest CSL Behring annual revenue is $7.9 b.
What is CSL Behring revenue per employee?
Latest CSL Behring revenue per employee is $1.1 m.
Who are CSL Behring competitors?
Competitors of CSL Behring include Biotest, Abeona Therapeutics and Octapharma.
Where is CSL Behring headquarters?
CSL Behring headquarters is located at 1020 1st Ave, King of Prussia.
Where are CSL Behring offices?
CSL Behring has offices in King of Prussia, Bradley, Kankakee, Olivos and in 31 other locations.
How many offices does CSL Behring have?
CSL Behring has 40 offices.
Receive alerts for 300+ data fields across thousands of companies